Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2013-005594-51-BE
EUCTR2013-005594-51-BEActive, not recruitingPhase 1

Gastrointestinal behavior of abirateronacetaat in healthy volunteers - Gastrointestinal behavior of abirateronacetaat

KU Leuven0 sites10 target enrollmentStarted: February 24, 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
KU Leuven
Enrollment
10
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •healthy volunteers
  • •age between 18 and 35
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 10
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •use of medication
  • •regular exposure to X-radiation last year

Investigators

Sponsor
KU Leuven

Similar Trials

Completed
Not Applicable
Effect of food on abiraterone in prostate cancer patients
CTRI/2018/07/014859All India Institute of Medical Sciences New Delhi18
Completed
Not Applicable
Evaluation of the gastrointestinal effects of breads containing in situ produced arabinoxylan-oligosaccharides in healthy volunteersGastrointestinal effects of arabinoxylan-oligosaccharidesDigestive System
ISRCTN17344943Puracor NV (Belgium)25
Completed
Not Applicable
Effects of intestinal Amarasate™ (a bitter hops extract) on gut function in healthy, lean volunteers.Healthy human gastrointestinal physiologyDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - DiabetesType 2 DiabetesObesity
ACTRN12620000503921Professor Christine Feinle-Bisset11
Active, not recruiting
Phase 1
The behavior of aprepitant in the stomach, small intestine and blood after the oral administratio
EUCTR2016-001156-22-BEKU Leuven - Drug Delivery and Disposition5
Active, not recruiting
Phase 1
Gastrointestinal behavior of itraconazole in healthy volunteershealthy volunteers (administration of antifungal drug)
EUCTR2011-005928-17-BEKatholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy5